Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Recruiting
Observational Study
Direct Acting Anticoagulant Adverse Reaction
Needle Injury
EMG
Peripheral Neuropathies
Mononeuropathies
Polyneuropathies
Neuromuscular Diseases (NMD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 70 (estimated)
- Sponsor
- Masaryk University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG.
The aim of the study is to determine whether needle EMG can be conside…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects must understand the nature of the study and must provide signed and dated written informed consent prior to conducting any study-related procedures
* Willing and able to comply with all protocol procedures
* subjects confirmed the daily (and recent) intake od direct a…
Contacts